Insider Trading: Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

2.13USD
18 Jun 2013
Price Change (% chg)

$-0.01 (-0.47%)
Prev Close
$2.14
Open
$2.18
Day's High
$2.18
Day's Low
$2.12
Volume
232,024
Avg. Vol
609,953
52-wk High
$4.50
52-wk Low
$1.06

Search Stocks
GCE HOLDINGS L L C Options Exercised: 0
Trade Date: Sunday, 30 Sep 2012 Price: 0.00
Title: Beneficial Owner of More than 10% Class Shares Held: 32,511,464
Type Traded: Direct Net Change in Shares This Filing: -32,511,464
» More Insider Trading

Institutional Holders

% Shares Owned: 91.02%
# of Holders: 63
Total Shares Held: 42,213,069
3 Mo. Net Change: -3,062,852
# New Positions: 8
# Closed Positions: 6
# Increased Positions: 27
# Reduced Positions: 18
# Net Buyers: 9

Officers & Directors

Name Age Since Current Position

Robert Jones

 54 2011 President, Chief Executive Officer, Director

Peter Clemens

 60 2004 Chief Financial Officer, Senior Vice President, Secretary

Robert Seiser

 49 2004 Vice President, Corporate Controller and Treasurer

J. Bradley Rivet

 59 2011 Vice President - Marketing

Albert Brzeczko

 56 2009 Vice President -Technical Affairs

James Emigh

 57 2011 Vice President - Corporate Development

George Ross

 71 2008 Independent Director

William Skelly

 62 2000 Independent Director

Immanuel Thangaraj

 42 2002 Independent Director

Bruce Wesson

 70 1998 Independent Director
Search Stocks